Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial.

Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial.

BACKGROUND:Group A streptococcus (GAS) is a serious human pathogen that affects people of different ages and socio-economic levels. Although vaccination is potentially one of the most effective methods to control GAS infection and its sequelae, few prototype vaccines have been investigated in humans...

Full description

Bibliographic Details
Main Authors: Silvana Sekuloski, Michael R Batzloff, Paul Griffin, William Parsonage, Suzanne Elliott, Jon Hartas, Peter O'Rourke, Louise Marquart, Manisha Pandey, Fran A Rubin, Jonathan Carapetis, James McCarthy, Michael F Good
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6028081?pdf=render

Internet

http://europepmc.org/articles/PMC6028081?pdf=render

Similar Items